http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020300-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_377e801d2a24db71676cc57123240f19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb02cb19d7d164d7cb1e6360928104e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbe1d40faa1ed62003e4b49d8b278688 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3744e89fb85054c7b635d765f1bcd8e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd61acc6837be909f6137ea4fecbac83 |
publicationDate | 2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-03020300-A1 |
titleOfInvention | Use of cyclopenta[g]quinazoline derivatives for treating cancer |
abstract | Cyclopenta[g]quinazolines of the formula (I): wherein: A is hydrogen or a group OR or NR0R1 wherein R?0 and R1¿ are each independently hydrogen C¿1-4? alkyl, C3-4 alkenyl, C3-4 alkynyl, C2-4 hydroxyalkyl, C2-4 halogenoalkyl or C1-4 cyanoalkyl, or R?0 and R1¿ together with the intermediate N form a five- or six-membered heterocylic ring; p is an integer in the range 1 to 4; R2 is hydrogen, C¿1-4? alkyl, C3-4 alkenyl, c3-4 alkynyl, C2-4 hydroxyalkyl, C2-4 halogenoalkyl or C1-4 cyanoalkyl; Ar?1¿ is phenylene, thiophenediyl, thiazolediyl, pyridinediyl or pyrimidinediyl which may optionally bear one or two subtituents selected from halogeno, hydroxy, amino, nitro, cyano, trifluoromethyl, C¿1-4? alkyl and C1-4 alkoxy; and R?3¿ is a group the following formula: (II) and pharmaceutically acceptable salts or esters may be used in the treatment of solid tumours. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466111-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009115776-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101977620-A |
priorityDate | 2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 813.